Watch Ticker

DiaMedica Therapeutics Inc. Common Stock

Go to DiaMedica Therapeutics Inc. Common Stock Website

$4.82

0.10 (2.12%)

Live

Previous Close

$4.72

Day Range

$4.77 - $5.09

Previous Day Range

$4.5 - $4.775

Market Cap

$231.2 million USD

Day Vol.

389006

Previous Day Vol.

291513

Currency

USD

Primary Exchange

Nasdaq

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main prod...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch

DiaMedica (DMAC) rises 10% as it doses the first patient in the relaunch of its pivotal study evaluating the lead candidate, DM199, to treat acute ischemic stroke.

Related tickers: ADMA, FGEN, DMAC, ANVS.

Read Full Article

Zacks Equity Research - DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

DiaMedica Therapeutics (DMAC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Related tickers: DMAC.

Read Full Article

Trending Tickers

Please sign in to view